We are live on
!
Find out more
VI
Versor Investments Portfolio holdings
AUM
$47.5M
1-Year Est. Return
100.43%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+100.43%
3 Year Est. Return
+204.71%
5 Year Est. Return
+565.87%
10 Year Est. Return
–
AUM
$567M
AUM Growth
-$46M
(-7.5%)
Cap. Flow
-$79.4M
Cap. Flow
% of AUM
-14%
Top 10 Holdings %
Top 10 Hldgs %
13.89%
Holding
981
New
300
Increased
159
Reduced
224
Closed
298
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BPMC
Blueprint Medicines
BPMC
|
+$9.14M |
| 2 |
FARO
Faro Technologies
FARO
|
+$9.14M |
| 3 |
SKX
Skechers
SKX
|
+$8.27M |
| 4 |
STR
Sitio Royalties
STR
|
+$6.88M |
| 5 |
GTLS
Chart Industries
GTLS
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BERY
Berry Global Group, Inc.
BERY
|
+$11.7M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$7.47M |
| 3 |
DFS
Discover Financial Services
DFS
|
+$7.45M |
| 4 |
HEES
H&E Equipment Services
HEES
|
+$6.59M |
| 5 |
ANSS
Ansys
ANSS
|
+$6.17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20% |
| 2 | Consumer Discretionary | 14.4% |
| 3 | Financials | 13.1% |
| 4 | Industrials | 12.64% |
| 5 | Healthcare | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SNCY
476
DELISTED
Sun Country Airlines
SNCY
| $371K | 0.07% |
31,600
-28,600
| -48% | -$314K |
|
477
Bristol-Myers Squibb
BMY
$132B
| $371K | 0.07% |
+8,012
| New | +$393K |
|
478
Cadence Design Systems
CDNS
$93.4B
| $370K | 0.07% |
+1,200
| New | +$349K |
|
|
CIVI
479
DELISTED
Civitas Resources
CIVI
| $369K | 0.07% |
13,400
-51,240
| -79% | -$1.48M |
|
480
Amphenol
APH
$209B
| $369K | 0.07% |
3,733
-967
| -21% | -$79.1K |
|
481
Adaptive Biotechnologies
ADPT
$3.97B
| $367K | 0.06% |
+31,500
| New | +$286K |
|
|
AXON
482
Axon Enterprise
AXON
$46.4B
| $366K | 0.06% |
442
-2,356
| -84% | -$1.6M |
|
483
First Bancorp
FBP
$4.38B
| $365K | 0.06% |
17,529
-44,148
| -72% | -$868K |
|
484
Primerica
PRI
$10B
| $365K | 0.06% |
1,332
+382
| +40% | +$101K |
|
485
nCino
NCNO
$2.1B
| $362K | 0.06% |
12,951
-117
| -0.9% | -$2.92K |
|
486
Usana Health Sciences
USNA
$286M
| $361K | 0.06% |
11,840
-1,160
| -9% | -$32.9K |
|
487
Astronics
ATRO
$3.84B
| $361K | 0.06% |
+12,946
| New | +$303K |
|
488
Lindsay Corp
LNN
$1.18B
| $361K | 0.06% |
+2,502
| New | +$334K |
|
|
CSGS
489
DELISTED
CSG Systems International
CSGS
| $358K | 0.06% |
5,476
+1,442
| +36% | +$90K |
|
490
Anterix
ATEX
$1.94B
| $357K | 0.06% |
+13,900
| New | +$407K |
|
491
Palantir
PLTR
$413B
| $356K | 0.06% |
+2,612
| New | +$306K |
|
492
Encore Capital Group
ECPG
$2.13B
| $353K | 0.06% |
+9,128
| New | +$331K |
|
493
Procore
PCOR
$8.67B
| $353K | 0.06% |
5,160
-12,153
| -70% | -$794K |
|
494
Watsco Inc
WSO
$13.6B
| $353K | 0.06% |
799
-2,602
| -77% | -$1.21M |
|
495
Liberty Media Series A
FWONA
$23.5B
| $352K | 0.06% |
3,703
-510
| -12% | -$43.1K |
|
496
Trupanion
TRUP
$1.18B
| $350K | 0.06% |
6,331
-23,169
| -79% | -$1.03M |
|
|
CVSA
497
Covista Inc
CVSA
$4.8B
| $348K | 0.06% |
+2,738
| New | +$324K |
|
498
Airbnb
ABNB
$106B
| $348K | 0.06% |
+2,629
| New | +$333K |
|
499
Universal Insurance Holdings
UVE
$1.23B
| $347K | 0.06% |
+12,500
| New | +$317K |
|
|
MPT
500
Medical Properties Trust
MPT
$2.81B
| $345K | 0.06% |
80,100
+12,400
| +18% | +$61.3K |
|
Similar funds
IPHI
EGI
PFA
FCM
RRC
CCG
CT
MCMC
Versor Investments's Q2 2025 Portfolio in Review
As of Q2 2025, Versor Investments held 981 positions worth $567M, down 7.5% from $613M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Versor Investments withdrew a net $79.4M in Q2 2025, closing 298 positions and reducing 224 holdings. Its most notable exit was Berry Global Group, Inc., an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Versor Investments opened a new position in Blueprint Medicines worth $11.3M.
- Versor Investments's largest Q2 2025 buy was Blueprint Medicines: 88,042 shares worth $11.3M.
- Versor Investments added most to Sitio Royalties in Q2 2025, an estimated $6.88M increase.
- Versor Investments's biggest Q2 2025 reduction was Carvana, cutting an estimated $3.12M.
- Versor Investments fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $11.7M.
- Versor Investments's ten largest holdings make up 14% of its $567M portfolio in Q2 2025.
- Versor Investments opened 300 new positions and closed 298 in Q2 2025.
- Versor Investments's portfolio value fell 7.5% quarter-over-quarter to $567M.
Based on Versor Investments's 13F filing for Q2 2025, filed 5 Aug 2025.